Evidence map›Paper›PMID 40515848›Full record

ArticleVirchows Archiv : an international journal of pathology2026

Basal cell adenoma with S100 protein-positive "stroma": a distinct triphasic salivary gland neoplasm characterized by CTNNB1 mutation.

Alena Skálová, Martina Bradová, Jan Laco, Tomáš Vaněček, Veronika Hájková, Petr Martínek, Marián Grendár, Giulia Querzoli, Ilmo Leivo, Michal Michal

Abstract read
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alena SkálováDepartment of Pathology, Faculty of Medicine, Sikl's, Charles University, E. Benese 13, 305 99, Plzen, Czech Republic. skalova@biopticka.cz.
Martina BradováDepartment of Pathology, Faculty of Medicine, Sikl's, Charles University, E. Benese 13, 305 99, Plzen, Czech Republic.
Jan LacoThe Fingerland Department of Pathology, Faculty of Medicine, Charles University, Hradec Kralove and University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Tomáš VaněčekMolecular and Genetic Laboratory, Bioptic Laboratory, Ltd, Plzen, Czech Republic.
Veronika HájkováMolecular and Genetic Laboratory, Bioptic Laboratory, Ltd, Plzen, Czech Republic.
Petr MartínekMolecular and Genetic Laboratory, Bioptic Laboratory, Ltd, Plzen, Czech Republic.
Marián GrendárMolecular and Genetic Laboratory, Bioptic Laboratory, Ltd, Plzen, Czech Republic.
Giulia QuerzoliPathology Unit, IRCCS Azienda Ospedaliero Universitaria Di Bologna, Bologna, Italy.
Ilmo Leivo *Institute of Biomedicine, Pathology, Department of Pathology, University of Turkuand, Turku University Hospital, Turku, Finland.
Michal Michal *Department of Pathology, Faculty of Medicine, Sikl's, Charles University, E. Benese 13, 305 99, Plzen, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Basal cell adenoma (BCA) is a benign salivary neoplasm that exhibits a divergent spectrum of growth patterns, including cribriform, tubular, trabecular, membranous, and solid. A subset of BCAs is characterized by the presence of abundant S100 protein-positive stroma, which makes this variant unique and potentially represents a hybrid lesion or an entity intermediate between BCA and pleomorphic adenoma (PA). From the authors' registry, we selected 17 cases of BCA with abundant S100 protein-positive stromal components and compared them with 7 cases of BCA without S100 protein-positive stroma, and 6 cases of myoepithelial cell-rich PAs. All cases were analyzed by immunohistochemistry (IHC) using antibodies to S100 protein, SOX10, PLAG1, HMGA2, p63/p40, cytokeratins, EMA, LEF1, and/or β-catenin. Next-generation sequencing (NGS), fluorescence in situ hybridization (FISH) for the rearrangement of PLAG1, and methylation analysis were performed. The BCA S100 protein stromal cell-rich group consisted of 7 males and 10 females with an average age of 62 years. Their tumors showed typical S100 protein-positive stroma, which was also positive for SOX10 in all cases. The stromal and/or epithelial components showed expression of LEF1 and β-catenin in 17 and 15 cases, respectively. HMGA2 IHC showed nuclear expression in one case while PLAG1 was negative in all cases. In 11 cases, one or more mutations were present, including CTNNB1 mutation (n = 11). The first control cohort of BCA without S100 protein-positive stroma consisted of 1 male and 6 females with an average age of 50 years. This group showed LEF1 and nuclear β-catenin expression in 1 and 2 cases, respectively. The second control group of PA (including 4 spindle-shaped cellular and 2 oncocytic PAs) was devoid of CTNNB1 mutations. Two cases presented with gene fusions, including MEG3::PLAG1 and ACTA2::PLAG1, and an additional two cases showed PLAG1 break. It has been proposed earlier that BCA is related to PA based on a shared biphasic nature and a divergent spectrum of growth patterns. Our findings suggest that BCAs with abundant S100 protein-positive stroma are tumors that morphologically display tricellular differentiation into inner (luminal) ductal epithelial cells, outer (abluminal) basaloid myoepithelial cells, and spindle-shaped stromal S100-positive cells (stromal abluminal). According to our investigation, BCAs with S100 protein-positive stroma represent a distinctive triphasic subset of BCA, which is substantially different from PA, both in immunoprofile and molecular underpinnings.

Indexed as

Adenomabeta CateninBiomarkers, TumorMutationS100 ProteinsSalivary Gland NeoplasmsStromal CellsAdenoma, PleomorphicAdultAgedAged, 80 and overFemaleHumansImmunohistochemistryMaleMiddle Agedbeta CateninBiomarkers, TumorCTNNB1 protein, humanS100 ProteinsBasal cell adenomaMethylation analysisMolecular diagnosticsNext-generation sequencingS100 protein–positive stromaSalivary gland

Identifiers

PMID40515848
PMCPMC12916997

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.